Search results
Fanconi anemia: Researchers say brain tumors are fatal when there is a double gene mutation
Medical Xpress· 12 hours agoFanconi anemia (FA) is a rare hereditary cancer predisposition disease characterized by bone marrow failure as well as endocrine and physical abnormalities. A key clinical feature in those affected ...
Albany Med participating in metastatic brain tumor study
FOX 23 News Albany· 7 days agoAlbany Medical Center will offer a clinical trial using GammaTile Therapy, an FDA-cleared,...
EMA CHMP recommends AstraZeneca’s Tagrisso for lung cancer
Pharmaceutical Technology via Yahoo Finance· 18 minutes ago“If approved in Europe, patients will have the option to be treated with Tagrisso alone, or with...
The use of new technologies expands understanding of brain tumors in children
Medical Xpress· 6 days agoA study used new molecular analyses to unravel the biological mechanisms of pediatric brain tumors and refine their classification. The research results ...
Isabella Strahan shares update after 3rd round of chemo for brain tumor
ABC News· 4 days agoIsabella Strahan is celebrating milestones missed amid her ongoing treatment for a malignant brain ...
MEDSIR's PRIMED Study Shows Promising Results for Preventing Sacituzumab Govitecan related Side...
Valley City Times Record· 2 days agoThe PRIMED study found a way to reduce treatment-related side effects among participants, decreasing...
Pfizer drug extends life for patients with rare lung cancer usually seen in nonsmokers
NBC Universal via AOL· 4 days agoPfizer’s lung cancer drug Lorbrena can extend life for patients with a rare form of the disease for...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 3 days agoResults from Phase 1 dose escalation trial of BDTX-1535 in GBM patients demonstrated a favorable safety and tolerability profile, and encouraging anti-tumor activity and duration ...
New research platform assesses brain cancer mutations during surgery
Medical Xpress· 5 days agoBrain cancer is difficult to treat when it starts growing, and a prevalent type, known as a glioma, has a poor five-year survival rate. In a new study published ...
Researchers create 'chameleon' compound that targets drug-resistant brain cancers
Medical Xpress· 18 hours agoThe research, published in the Journal of the American Chemical Society, is a crucial step in the development of so-called "chameleon compounds" that may be used to target an array of pernicious ...